Article
Effective Synthesis of mRNA during In Vitro Transcription with Fewer Impurities Produced.
Molecules (Basel, Switzerland) - 5 Oct 2024
He Wei, Geng Qi, Ji Guiying, Li Ji, Wang Dan, He Yucai, Jin Qiuheng, Ye Jianren
Abstract excerpt
The remarkable efficacy of COVID-19 vaccines has established mRNA as a highly promising biomedical technology. However, the adequate application of mRNA therapeutics necessitates additional measures to mitigate the inherent immunogenicity, which is predominantly caused by dsRNA. As a byproduct of the in vitro transcription of mRNA, dsRNA was reported to be originated through several distinct mechanisms, including...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
